Fingolimod Capsule
Product Images NDC 62332-228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 62332-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Capsules (Fingolimod 05)

30 Capsules (Fingolimod 05)
Fingolimod Capsules 0.5 mg oral capsules label from Alembic Pharmaceuticals Inc., NDC 62332-228-30. The label indicates 30 capsules per package and includes storage instructions, active ingredient amount per capsule (0.56 mg fingolimod hydrochloride equivalent to 0.5 mg fingolimod), dispensing information, and manufacturer details for both Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA.*
FDA Label Image

Figure 1 (Fingolimod Fig1)

Figure 1 (Fingolimod Fig1)
A line graph showing the percentage of patients with three-month confirmed progression over time (days) compared between Fingolimod 0.5 mg and placebo treatment groups. The x-axis represents time in days up to 720 days, and the y-axis represents the percentage of patients, reaching approximately 18% for Fingolimod and 24% for placebo at the study's end.*
FDA Label Image

Structure (Fingolimod Str)

Structure (Fingolimod Str)
Chemical structure of Fingolimod illustrating the molecular configuration with hydroxyl, amine, and chloride groups along its hydrocarbon chain and aromatic ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.